Related Experiment Video
Updated: Jun 26, 2026
09:27
Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
Published on: April 2, 2021
Micafungin: a sulfated echinocandin.
1Biotechnology Research Center, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan. hashimot@pu-toyama.ac.jp
The Journal of Antibiotics
|January 10, 2009
Summary
Micafungin, an echinocandin antifungal, combats serious fungal infections. It uniquely inhibits fungal cell-wall synthesis by targeting 1,3-beta-glucan synthase, differing from other echinocandins.
Area of Science:
- Medicinal Chemistry
- Mycology
- Pharmacology
Background:
- Micafungin is a key echinocandin antifungal used globally for severe fungal infections.
- It is semi-synthesized from a natural product, FR901379, derived from Coleophoma empetri.
- Its unique sulfate moiety confers water solubility, distinguishing it from other echinocandins.
Purpose of the Study:
- To describe the chemical nature and mechanism of action of micafungin.
- To highlight micafungin's unique properties within the echinocandin class.
- To underscore its role in treating life-threatening fungal infections.
Main Methods:
- Semi-synthesis involving enzymatic deacylation and chemical reacylation.
- Characterization of water solubility attributed to a sulfate group.
- Investigation of its inhibitory action on 1,3-beta-glucan synthase.
Main Results:
- Micafungin's semi-synthesis from FR901379 was achieved.
- The sulfate group was identified as the source of its water solubility.
- Micafungin demonstrated potent inhibition of fungal 1,3-beta-glucan synthase.
Conclusions:
- Micafungin's unique structure and water solubility enhance its clinical utility.
- Its mechanism of action targets a critical fungal enzyme, providing broad-spectrum activity.
- Micafungin represents an important advancement in antifungal chemotherapy.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:29Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...